These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23587617)

  • 1. [From donor to recipient: transfusion chain specificities in the French ultra-marine areas].
    Richard P; Ould Amar K
    Transfus Clin Biol; 2013 May; 20(2):59-67. PubMed ID: 23587617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of blood transfusion-associated Chikungunya fever during the 2009 epidemic in Songkhla Province, Thailand.
    Appassakij H; Promwong C; Rujirojindakul P; Wutthanarungsan R; Silpapojakul K
    Transfusion; 2014 Aug; 54(8):1945-52. PubMed ID: 24527811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion and sickle cell disease].
    Boulat C
    Transfus Clin Biol; 2013 May; 20(2):68-71. PubMed ID: 23597585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The expansion of vector-borne diseases and the implications for blood transfusion safety: The case of West Nile Virus, dengue and chikungunya].
    Paty MC
    Transfus Clin Biol; 2013 May; 20(2):165-73. PubMed ID: 23622840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Health alert management and emerging risk].
    Pillonel J
    Transfus Clin Biol; 2010 Dec; 17(5-6):291-5. PubMed ID: 21051258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
    Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F
    Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply].
    Meunier N; Rodet M; Bonin P; Chadebech P; Chami B; Lee K; Habibi A; Bachir D; Galactéros F; Bierling P; Noizat-Pirenne F
    Transfus Clin Biol; 2008 Dec; 15(6):377-82. PubMed ID: 19026581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malaria and blood transfusion.
    Kitchen AD; Chiodini PL
    Vox Sang; 2006 Feb; 90(2):77-84. PubMed ID: 16430664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The yield of temporary exclusion of blood donors, exposed to emerging infections abroad.
    Lieshout-Krikke RW; Zaaijer HL; Prinsze FJ
    Vox Sang; 2013 Jan; 104(1):12-8. PubMed ID: 22775433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines.
    Kitchen AD; Barbara JA; Hewitt PE
    Vox Sang; 2005 Aug; 89(2):77-80. PubMed ID: 16101687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race-related red cell alloantibody problems.
    Issitt PD
    Br J Biomed Sci; 1994 Jun; 51(2):158-67. PubMed ID: 8049613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European strategies against the parasite transfusion risk.
    Reesink HW
    Transfus Clin Biol; 2005 Feb; 12(1):1-4. PubMed ID: 15814284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007.
    Brouard C; Bernillon P; Quatresous I; Pillonel J; Assal A; De Valk H; Desenclos JC;
    Transfusion; 2008 Jul; 48(7):1333-41. PubMed ID: 18298600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stating technical requirements and deferral criteria for whole blood donation].
    Danic B
    Transfus Clin Biol; 2005 Jul; 12(3):287-9. PubMed ID: 15963750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion.
    Rasonglès P; Angelini-Tibert MF; Simon P; Currie C; Isola H; Kientz D; Slaedts M; Jacquet M; Sundin D; Lin L; Corash L; Cazenave JP
    Transfusion; 2009 Jun; 49(6):1083-91. PubMed ID: 19309473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chikungunya virus: possible impact on transfusion medicine.
    Petersen LR; Stramer SL; Powers AM
    Transfus Med Rev; 2010 Jan; 24(1):15-21. PubMed ID: 19962571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is transplantation an alternative to the transfusional impasse in sickle cell disease?].
    Bernaudin F; Kuentz M
    Transfus Clin Biol; 2017 Sep; 24(3):232-236. PubMed ID: 28648733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood donor hemovigilance: impact for donor and recipient safety].
    Hauser L; Beyloune A; Simonet M; Bierling P
    Transfus Clin Biol; 2013 May; 20(2):99-103. PubMed ID: 23587614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.